Effects of treatment and withdrawal with inhaled beclomethasone/formoterol on lung inflammation in COPD

Trial Profile

Effects of treatment and withdrawal with inhaled beclomethasone/formoterol on lung inflammation in COPD

Completed
Phase of Trial: Phase III

Latest Information Update: 27 Aug 2014

At a glance

  • Drugs Beclometasone/formoterol (Primary)
  • Indications Chronic obstructive pulmonary disease
  • Focus Therapeutic Use
  • Most Recent Events

    • 16 Aug 2014 Status changed from recruiting to completed according to European Clinical Trials Database record.
    • 01 Jul 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top